Since FA/BRCA deficient cells and other cells that are deficient in HR are highly susceptible to PARP small molecule inhibitors [11, 20, 21], we hypothesized that PAK inhibition could sensitize PAK1 amplified or overexpressing beast cancer cells to PARP pharmacological inhibition. This evidence concerns the gene PARP1 and cancer.